Walgreens Boots Alli

WBA
Real-time BATS EXCHANGE - 04/06 10:35:45 am
41.96USD
+3.17%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period August 2019 2020 (e)
Sales 136 866 139 524
EBITDA 8 413 7 695
Operating profit (EBIT) 6 942 6 131
Pre-Tax Profit (EBT) 4 527 4 174
Net income 3 982 3 621
P/E ratio 11,9x 9,78x
EPS ( $ ) 4,31 4,12
Dividend per Share ( $ ) 1,78 1,85
Yield 3,47% 4,59%
Reference price ( $ ) 51,190 40,320
Announcement Date 10/28/2019
11:00am
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period August 2019 2020 (e)
Debt 15 813 15 293
Finance - -
Operating income (EBITDA) 8 413 7 695
Leverage
(Debt/EBITDA)
1,88x 1,99x
Capital Expenditure 1 702 1 841
Free Cash Flow (FCF) 3 892 4 806
Book Value Per Share (BVPS) ( $ ) 26,3 31,9
Cash Flow per Share ( $ ) 6,06 6,39
Announcement Date 10/28/2019
11:00am
-
Balance Sheet Analysis
Financial Ratios
Size 2020e 2021e
Capitalization 35 370 M $ -
Entreprise Value (EV) 50 662 M $ 49 271 M $
Valuation 2020e 2021e
P/E ratio (Price / EPS) 9,78x 7,88x
Capitalization / Revenue 0,25x 0,25x
EV / Revenue 0,36x 0,35x
EV / EBITDA 6,58x 6,29x
Yield (DPS / Price) 4,59% 4,76%
Price to book (Price / BVPS) 1,26x 1,17x
Profitability 2020e 2021e
Operating Margin (EBIT / Sales) 4,39% 4,56%
Operating Leverage (Delta EBIT / Delta Sales) - 2,41x
Net Margin (Net Profit / Revenue) 2,60% 3,05%
ROA (Net Profit / Asset) 5,65% 5,71%
ROE (Net Profit / Equities) 17,7% 18,5%
Rate of Dividend 44,8% 37,5%
Balance Sheet Analysis 2020e 2021e
CAPEX / Sales   1,32% 1,20%
Cash Flow / Sales 4,02% 4,73%
Capital Intensity (Assets / Sales) 0,46x 0,53x
Financial Leverage (Net Debt / EBITDA) 1,99x 1,73x
Price Earning Ratio
BNA & Dividende